Your privacy, your choice

We use essential cookies to make sure the site can function. We also use optional cookies for advertising, personalisation of content, usage analysis, and social media.

By accepting optional cookies, you consent to the processing of your personal data - including transfers to third parties. Some third parties are outside of the European Economic Area, with varying standards of data protection.

See our privacy policy for more information on the use of your personal data.

for further information and to change your choices.

You are viewing the site in preview mode

Skip to main content
Fig. 1 | Journal of Translational Medicine

Fig. 1

From: Ameliorative effects of mesenchymal stromal cells on senescence associated phenotypes in naturally aged rats

Fig. 1

Research process and identification of umbilical cord mesenchymal stromal cells. In this study, UC-MSCs are identified through surface markers and their potential for adipogenic, osteogenic, and chondrogenic differentiation. (A) The research flow diagram summarizes the experimental animals used in this study, the experimental grouping, treatment methods, and detection techniques. (B) Flow cytometry identifies the surface markers of the UC-MSCs cultured and isolated in this study, demonstrating that the proportion of cells positive for CD44, CD90, and CD105 is ≥ 95%, while the proportion of cells positive for CD11b, CD34, and CD45 is ≤ 5%. (C) Alizarin Red staining identifies the cells’ osteogenic differentiation potential. Scale = 200 μm. (D) Oil Red O staining identifies the cells’ adipogenic differentiation potential. Scale = 200 μm. (E) Toluidine Blue staining identifies the cells’ chondrogenic differentiation potential. Scale = 200 μm

Back to article page